Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate... Read More
Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate th... Read More
Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy o... Read More
Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More
Singapore, Aug. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129718) titled 'First-in-Man Study of the Broadband Synergistic Pulsed Ablation System fo... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129722) titled 'Effectiveness of Different Exercise Rehabilitation Programs for Patients ... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129720) titled 'Comparative study on the medium and long-term benefits of ultrasound-guid... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129723) titled 'Staged fixation with Monteggia frame combined with delayed internal fixat... Read More
Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129725) titled 'A multiple-dose, randomized, multicenter, phase II clinical trial to eval... Read More